Annual report
3840.TEDINET S100YKGU
Period2025-04-01 → 2026-03-31
Filed2026-06-25
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 133
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.4bn | 2025-04-01 → 2026-03-31 | Cons. | Net sales |
| Revenue | ¥2.3bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥2.3bn | 2023-04-01 → 2024-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.0bn | 2022-04-01 → 2023-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.1bn | 2021-04-01 → 2022-03-31v | Cons. | Net sales (5-year summary) |
| Operating income | −¥774m | 2025-04-01 → 2026-03-31 | Cons. | Operating income |
| Operating income | −¥208m | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Ordinary income | −¥961m | 2025-04-01 → 2026-03-31 | Cons. | Ordinary income |
| Ordinary income | −¥229m | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | −¥168m | 2023-04-01 → 2024-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥224m | 2022-04-01 → 2023-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥737m | 2021-04-01 → 2022-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | −¥1.3bn | 2025-04-01 → 2026-03-31 | Cons. | Income before income taxes |
| Profit before tax | −¥269m | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Net income (owners) | −¥1.3bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥277m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥176m | 2023-04-01 → 2024-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥256m | 2022-04-01 → 2023-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥746m | 2021-04-01 → 2022-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | −¥1.3bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss |
| Net income | −¥277m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Total assets | ¥2.5bn | at 2026-03-31 | Cons. | Assets |
| Total assets | ¥3.3bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥1.7bn | at 2024-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥1.5bn | at 2023-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥1.3bn | at 2022-03-31v | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥621m | at 2026-03-31 | Cons. | Liabilities |
| Total liabilities | ¥777m | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥1.9bn | at 2026-03-31 | Cons. | Net assets |
| Net assets / equity | ¥2.5bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥1.2bn | at 2024-03-31v | Cons. | Net assets |
| Net assets / equity | ¥1.1bn | at 2023-03-31v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥470m | at 2022-03-31v | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥357m | at 2026-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥155m | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥357m | at 2026-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥155m | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥297m | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥173m | at 2023-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥345m | at 2022-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | −¥435m | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥539m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥77m | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥352m | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥836m | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥319m | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥525m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥87m | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥114m | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥24m | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥957m | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥914m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥288m | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥281m | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥999m | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥-16.52 | 2025-04-01 → 2026-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-4.36 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-3.31 | 2023-04-01 → 2024-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-5.46 | 2022-04-01 → 2023-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-20.95 | 2021-04-01 → 2022-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥23.05 | at 2026-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥33.47 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥21.2 | at 2024-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥20.91 | at 2023-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥12.4 | at 2022-03-31v | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 75.4% | at 2026-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 75.5% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 71.2% | at 2024-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.3% | at 2023-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 36.0% | at 2022-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Employees | 50 | at 2026-03-31 | Cons. | Number of employees |
| Employees | 61 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 46 | at 2024-03-31v | Cons. | Number of employees |
| Employees | 56 | at 2023-03-31v | Cons. | Number of employees |
| Employees | 50 | at 2022-03-31v | Cons. | Number of employees |
| Revenue | ¥144m | 2025-04-01 → 2026-03-31 | Standalone | Net sales |
| Revenue | ¥100m | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥82m | 2023-04-01 → 2024-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥132m | 2022-04-01 → 2023-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥95m | 2021-04-01 → 2022-03-31v | Standalone | Net sales (5-year summary) |
| Operating income | −¥122m | 2025-04-01 → 2026-03-31 | Standalone | Operating income |
| Operating income | −¥109m | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Ordinary income | −¥1.2bn | 2025-04-01 → 2026-03-31 | Standalone | Ordinary income |
| Ordinary income | −¥172m | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | −¥132m | 2023-04-01 → 2024-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥268m | 2022-04-01 → 2023-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥666m | 2021-04-01 → 2022-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | −¥1.5bn | 2025-04-01 → 2026-03-31 | Standalone | Income before income taxes |
| Profit before tax | −¥186m | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Net income | −¥1.5bn | 2025-04-01 → 2026-03-31 | Standalone | Profit loss |
| Net income | −¥182m | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | −¥114m | 2023-04-01 → 2024-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | −¥298m | 2022-04-01 → 2023-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | −¥1.1bn | 2021-04-01 → 2022-03-31v | Standalone | Net income loss (5-year summary) |
| Total assets | ¥1.9bn | at 2026-03-31 | Standalone | Assets |
| Total assets | ¥2.5bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥1.1bn | at 2024-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥946m | at 2023-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥982m | at 2022-03-31v | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥293m | at 2026-03-31 | Standalone | Liabilities |
| Total liabilities | ¥39m | at 2025-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.6bn | at 2026-03-31 | Standalone | Net assets |
| Net assets / equity | ¥2.5bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥1.1bn | at 2024-03-31v | Standalone | Net assets |
| Net assets / equity | ¥922m | at 2023-03-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥334m | at 2022-03-31v | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥310m | at 2026-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥64m | at 2025-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥-19.84 | 2025-04-01 → 2026-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-2.87 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-2.14 | 2023-04-01 → 2024-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-6.36 | 2022-04-01 → 2023-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-30.54 | 2021-04-01 → 2022-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥19.7 | at 2026-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥33.19 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥19.15 | at 2024-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥17.46 | at 2023-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥8.73 | at 2022-03-31v | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 84.8% | at 2026-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 97.7% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 96.2% | at 2024-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 95.1% | at 2023-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 32.8% | at 2022-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 82,680,236 | at 2026-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 73,377,036 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 56,309,516 | at 2024-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 51,509,516 | at 2023-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 36,944,500 | at 2022-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Employees | 9 | at 2026-03-31 | Standalone | Number of employees |
| Employees | 8 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 3 | at 2024-03-31v | Standalone | Number of employees |
| Employees | 4 | at 2023-03-31v | Standalone | Number of employees |
| Employees | 12 | at 2022-03-31v | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 62
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2025-04-01 → 2026-03-31 | −¥23m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-04-01 → 2026-03-31 | −¥23m |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2026-03-31 | −¥160m |
| AI Technologyreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥50m |
| AI Technologyreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥50m |
| AI Technologyreportable segment | segment profit | 2025-04-01 → 2026-03-31 | −¥167m |
| Beauty And Wellness Businessreportable segment | employees | at 2026-03-31 | 11 pure |
| Beauty And Wellness Businessreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥856m |
| Beauty And Wellness Businessreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥856m |
| Beauty And Wellness Businessreportable segment | segment profit | 2025-04-01 → 2026-03-31 | −¥82m |
| Cosmetics Businessreportable segment | employees | at 2026-03-31 | 15 pure |
| Cosmetics Businessreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥949m |
| Cosmetics Businessreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥949m |
| Cosmetics Businessreportable segment | segment profit | 2025-04-01 → 2026-03-31 | −¥248m |
| Investment Businessreportable segment | employees | at 2026-03-31 | 1 pure |
| Investment Businessreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥40m |
| Investment Businessreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥40m |
| Investment Businessreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥38m |
| Market Expansion Businessreportable segment | employees | at 2026-03-31 | 2 pure |
| Market Expansion Businessreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥2m |
| Market Expansion Businessreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥2m |
| Market Expansion Businessreportable segment | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥50,000 |
| Market Expansion Businessreportable segment | segment profit | 2025-04-01 → 2026-03-31 | −¥37m |
| Regenerative Medicine Related Businessreportable segment | employees | at 2026-03-31 | 10 pure |
| Regenerative Medicine Related Businessreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥489m |
| Regenerative Medicine Related Businessreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥465m |
| Regenerative Medicine Related Businessreportable segment | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥23m |
| Regenerative Medicine Related Businessreportable segment | segment profit | 2025-04-01 → 2026-03-31 | −¥54m |
| Sustainable Businessreportable segment | employees | at 2026-03-31 | 3 pure |
| Sustainable Businessreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥8m |
| Sustainable Businessreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥8m |
| Sustainable Businessreportable segment | segment profit | 2025-04-01 → 2026-03-31 | −¥64m |
| —segment total | revenue | 2025-04-01 → 2026-03-31 | ¥2.4bn |
| —segment total | revenue external | 2025-04-01 → 2026-03-31 | ¥2.4bn |
| —segment total | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥23m |
| —segment total | segment profit | 2025-04-01 → 2026-03-31 | −¥614m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2025-03-31 | −¥126m |
| AI Technologyreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥6m |
| AI Technologyreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥6m |
| AI Technologyreportable segment | segment profit | 2024-04-01 → 2025-03-31 | −¥11m |
| Beauty And Wellness Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥1.0bn |
| Beauty And Wellness Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥1.0bn |
| Beauty And Wellness Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥42m |
| Cosmetics Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥799m |
| Cosmetics Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥799m |
| Cosmetics Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | −¥44m |
| Investment Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥12m |
| Investment Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥12m |
| Investment Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥12m |
| Market Expansion Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥8m |
| Market Expansion Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥8m |
| Market Expansion Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | −¥5m |
| Regenerative Medicine Related Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥364m |
| Regenerative Medicine Related Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥364m |
| Regenerative Medicine Related Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | −¥38m |
| Sustainable Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥22m |
| Sustainable Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥22m |
| Sustainable Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | −¥39m |
| —segment total | revenue | 2024-04-01 → 2025-03-31 | ¥2.3bn |
| —segment total | revenue external | 2024-04-01 → 2025-03-31 | ¥2.3bn |
| —segment total | segment profit | 2024-04-01 → 2025-03-31 | −¥82m |
| Investment Businessreportable segment | employees | at 2026-03-31 | 1 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,345
| Item | Context | Value | Unit |
|---|---|---|---|
| Total return on share price index | Prior3YearInstant_NonConsolidatedMember | 1.079 | |
| Total return on share price index | Prior2YearInstant_NonConsolidatedMember | 1.525 | |
| Total return on share price index | Prior1YearInstant_NonConsolidatedMember | 1.502 | |
| Total return on share price index | CurrentYearInstant_NonConsolidatedMember | 2.022 | |
| Performance description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row1Member | 25.5 | |
| Targets description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row1Member | 50 | |
| Performance description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row2Member | 16.7 | |
| Targets description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row2Member | 30 | |
| Research and development expenses research and development activities | CurrentYearDuration | 23655000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E05674-000CosmeticsBusinessReportableSegmentsMember | 6676000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E05674-000BeautyAndWellnessBusinessReportableSegmentsMember | 8561000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E05674-000SustainableBusinessReportableSegmentsMember | 1487000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E05674-000RegenerativeMedicineRelatedBusinessReportableSegmentsMember | 4587000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E05674-000AITechnologyReportableSegmentsMember | 2342000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration | 57293000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E05674-000SustainableBusinessReportableSegmentsMember | 21192000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E05674-000RegenerativeMedicineRelatedBusinessReportableSegmentsMember | 20000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E05674-000AITechnologyReportableSegmentsMember | 4312000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 82680236 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 82680236 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 82680236 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 82680236 | |
| Number of shares constituting one unit | CurrentYearInstant_OrdinaryShareMember | 100 | |
| Number of shareholders national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shareholders financial institutions | CurrentYearInstant_OrdinaryShareMember | 1 | |
| Number of shareholders financial service providers | CurrentYearInstant_OrdinaryShareMember | 21 | |
| Number of shareholders other corporations | CurrentYearInstant_OrdinaryShareMember | 56 | |
| Number of shareholders foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 24 | |
| Number of shareholders foreign individual investors | CurrentYearInstant_OrdinaryShareMember | 54 | |
| Number of shareholders individuals and others | CurrentYearInstant_OrdinaryShareMember | 9154 | |
| Number of shareholders total | CurrentYearInstant_OrdinaryShareMember | 9310 | |
| Number of shares held number of units national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shares held number of units financial institutions | CurrentYearInstant_OrdinaryShareMember | 703 | |
| Number of shares held number of units financial service providers | CurrentYearInstant_OrdinaryShareMember | 26070 | |
| Number of shares held number of units other corporations | CurrentYearInstant_OrdinaryShareMember | 406937 | |
| Number of shares held number of units foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 8305 | |
| Number of shares held number of units foreign individual investors | CurrentYearInstant_OrdinaryShareMember | 1397 | |
| Number of shares held number of units individuals and others | CurrentYearInstant_OrdinaryShareMember | 383314 | |
| Number of shares held number of units total | CurrentYearInstant_OrdinaryShareMember | 826726 | |
| Number of shares held shares less than one unit | CurrentYearInstant_OrdinaryShareMember | 7636 | |
| Percentage of shareholdings national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Percentage of shareholdings financial institutions | CurrentYearInstant_OrdinaryShareMember | 0.0008 | |
| Percentage of shareholdings financial service providers | CurrentYearInstant_OrdinaryShareMember | 0.0315 | |
| Percentage of shareholdings other corporations | CurrentYearInstant_OrdinaryShareMember | 0.4922 | |
| Percentage of shareholdings foreigners other than individuals | CurrentYearInstant_OrdinaryShareMember | 0.0100 | |
| Percentage of shareholdings foreign individuals | CurrentYearInstant_OrdinaryShareMember | 0.0016 | |
| Percentage of shareholdings individuals and others | CurrentYearInstant_OrdinaryShareMember | 0.4636 | |
| Number of shares held | CurrentYearInstant_No1MajorShareholdersMember | 30516200 | |
| Shareholding ratio | CurrentYearInstant_No1MajorShareholdersMember | 0.369 | |
| Number of shares held | CurrentYearInstant_No2MajorShareholdersMember | 4308000 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |